PaC

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

Cynara scolymus, Quantity: 18 mg (Equivalent: Cynara scolymus, Qty 108 mg); Sambucus nigra, Quantity: 9 mg (Equivalent: Sambucus nigra, Qty 54 mg; Equivalent: anthocyanins calculated as cyanidin chloride (of Sambucus nigra), Qty 5.4 mg); Camellia sinensis, Quantity: 13.5 mg (Equivalent: Camellia sinensis, Qty 81 mg; Equivalent: caffeine, Qty 0.85 mg; Equivalent: catechins (of Camellia sinensis), Qty 8.5 mg); Citrus X paradisi, Quantity: 37.5 mg (Equivalent: Citrus X paradisi, Qty 225 mg); Trifolium pratense, Quantity: 18 mg (Equivalent: Trifolium pratense, Qty 108 mg; Equivalent: Daidzein, Qty 10.8 mg); Coffea canephora, Quantity: 13.5 mg (Equivalent: Coffea canephora, Qty 81 mg; Equivalent: chlorogenic acids (of Coffea canephora), Qty 10.5 mg; Equivalent: caffeine, Qty 0.8 mg); Punica granatum, Quantity: 31.5 mg (Equivalent: Punica granatum, Qty 189 mg; Equivalent: Ellagic acid (of Punica granatum), Qty 18.9 mg); Kaempferia galanga, Quantity: 9 mg (Equivalent: Kaempferia galanga, Qty 54 mg)

Available from:

BlueSkyGreenEarth Herbs Pty Ltd

INN (International Name):

Camellia sinensis,Citrus X paradisi,Coffea canephora,Cynara scolymus,Kaempferia galanga,Punica granatum,Sambucus nigra,Trifolium

Pharmaceutical form:

Capsule, hard

Composition:

Excipient Ingredients: hypromellose; purified water

Administration route:

Oral

Class:

Medicine Listed

Therapeutic indications:

Antioxidant/Reduce free radicals formed in the body

Product summary:

Visual Identification: ;

Authorization status:

Listed

Authorization date:

2011-11-04